Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,946,754
-$328,162 QoQ
Shares Held
23,324
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#719
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jacobi Capital Management LLC holds $62,099,576 across 14 Drug Manufacturers - General names. GILD ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,180 | $17,007,918 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,539 | $9,192,761 | |
| 3 | JNJ |
Johnson & Johnson
|
33,028 | $8,388,121 | |
| 4 | ABBV |
AbbVie Inc.
|
32,674 | $8,222,085 | |
| 5 | AMGN |
Amgen Inc
|
12,553 | $4,545,692 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
64,849 | $3,736,599 | |
| 7 | PFE |
Pfizer Inc
|
133,653 | $3,218,364 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
23,324 | $2,946,754 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,946,754 | 23,324 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,274,916 | 23,498 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,844,744 | 23,177 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,572,869 | 23,179 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,564,755 | 23,133 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,593,509 | 23,146 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $2,500,455 | 27,070 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,273,070 | 27,112 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,294,396 | 18,866 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,249,938 | 17,064 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,382,111 | 17,061 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,271,207 | 16,963 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,376,624 | 17,862 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,614,845 | 19,463 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,692,361 | 19,713 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,258,105 | 20,394 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,242,690 | 20,105 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,109,693 | 18,666 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,186,810 | 16,345 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,059,764 | 15,172 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,063,336 | 15,442 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,002,863 | 15,517 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $897,495 | 15,405 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $837,899 | 13,260 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $928,742 | 12,071 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $893,232 | 11,948 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||